Targeted therapy against EGFR and VEGFR using ZD6474 enhances the therapeutic potential of UV-B phototherapy in breast cancer cells

類似資料

• ZD6474 – a novel inhibitor of VEGFR and EGFR tyrosine kinase activity
  著者:: Ryan, A J, 等
  出版事項: (2005)
• Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma
  著者:: Yoshikawa, D, 等
  出版事項: (2009)
• Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small cell lung cancer
  著者:: Shibuya, Keiko, 等
  出版事項: (2007)
• ZD6474 in combination with paclitaxel and UVB irradiation enhances the antiproliferative effect and apoptosis on breast carcinoma
  著者:: Sarkar, S, 等
  出版事項: (2009)
• ZD6474 – clinical experience to date
  著者:: Heymach, J V
  出版事項: (2005)